Sakar Healthcare is trading 5% up at βΉ1,185.00 after broader healthcare-sector strength.
- The healthcare sector is up 1.27% amid renewed biotechnology optimism.
- No fresh company-specific announcement was identified for September 25, 2026.
- Oncology approvals across the EU, UK and Canada announced in early September remain supportive background, but do not directly explain todayβs move.